Biomarkers of Inflammation and Fibrosis in Conduction Disorders After TAVI
Recruiting
Observational Study
TAVI(Transcatheter Aortic Valve Implantation)
Conduction Disorder
Aortic Stenosis
Permanent Pacemaker Implantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 102 (estimated)
- Sponsor
- Clinical Hospital Center Rijeka · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prediction of conduction disorders (CDs) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) is an important and complex process with a significant impact on patient outcomes. The goal of this observational prospective trial is to investigate the role of pre-procedural values of systemic biomarkers of inflammation and fibrosis in the prediction of…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written consent to participate in the trial
* Diagnosis of severe AS according to current European Society of Cardiology (ESC) guidelines for valvular heart disease
Exclusion Criteria:
* Acute infectious disease
* Chronic inflammatory or autoimmune disease
* Corticosteroid o…
Contacts